These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 19640745)

  • 1. Monitoring anticoagulation of patients with antiphospholipid antibodies on cardiopulmonary bypass.
    Naggs TA
    J Cardiothorac Vasc Anesth; 2010 Aug; 24(4):734-5. PubMed ID: 19640745
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticoagulation management in a patient with antiphospholipid antibodies requiring repeat sternotomy.
    Mazzeffi M; Stone M; Stelzer P; Reich DL
    J Cardiothorac Vasc Anesth; 2010 Jun; 24(3):469-70. PubMed ID: 19525127
    [No Abstract]   [Full Text] [Related]  

  • 3. Venous thrombosis in the antiphospholipid syndrome.
    Farmer-Boatwright MK; Roubey RA
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):321-5. PubMed ID: 19228605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Could Anticoagulation or Antiaggregation Treatment Be Ceased in Patients With Primary Antiphospholipid Syndrome When Antiphospholipid Antibodies Become Persistently Negative?
    Hindilerden F; Yonal-Hindilerden I; Diz-Kucukkaya R
    J Clin Rheumatol; 2017 Sep; 23(6):350-353. PubMed ID: 28832383
    [No Abstract]   [Full Text] [Related]  

  • 5. Point-of-care testing of the international normalized ratio in patients with antiphospholipid antibodies.
    Perry SL; Samsa GP; Ortel TL
    Thromb Haemost; 2005 Dec; 94(6):1196-202. PubMed ID: 16411394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring oral anticoagulation may require determination of single coagulation factor activities in patients with antiphospholipid syndrome.
    Sucker C; Wenzel F; Zotz RB; Hetzel GR; Scharf RE
    J Rheumatol; 2006 Sep; 33(9):1881-2. PubMed ID: 16881092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
    Despotis GJ; Joist JH
    J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dramatic response of severe headaches to anticoagulation in a patient with antiphospholipid syndrome.
    Asherson RA; Giampaulo D; Singh S; Sulman L
    J Clin Rheumatol; 2007 Jun; 13(3):173-4. PubMed ID: 17551389
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral anticoagulation monitoring.
    Macaulay D
    Br J Gen Pract; 1997 Nov; 47(424):747-8. PubMed ID: 9519527
    [No Abstract]   [Full Text] [Related]  

  • 10. Managing antiphospholipid antibodies and antiphospholipid syndrome in children.
    Kamat AV; D'Cruz DP; Hunt BJ
    Haematologica; 2006 Dec; 91(12):1674-80. PubMed ID: 17145604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapsing splenic vein thrombosis associated with antiphospholipid antibodies in a patient with wegener granulomatosis.
    Steen KS; Peters MJ; Zweegman S; de Groot PG; Voskuyl AE
    J Clin Rheumatol; 2007 Apr; 13(2):92-3. PubMed ID: 17414539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of systemic anticoagulation during cardiopulmonary bypass.
    Bidstrup BP
    Ann Thorac Surg; 1996 Mar; 61(3):781-2. PubMed ID: 8619692
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anticoagulant therapy and cardiopulmonary bypass].
    Lespron Robles Mdel C; Molina Méndez J
    Arch Cardiol Mex; 2007; 77 Suppl 4():S4-185-93. PubMed ID: 18938724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiopulmonary support in the intensive care unit.
    Cone M; Hoffman M; Jessen D; Posa P; Dailey C; Rybowiak L
    Am J Crit Care; 1992 Jul; 1(1):98-106; quiz 107-8. PubMed ID: 1307885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombosis in the antiphospholipid-antibody syndrome.
    Violi F; Ferro D; Valesini G
    N Engl J Med; 1995 Sep; 333(10):665; author reply 666-7. PubMed ID: 7637735
    [No Abstract]   [Full Text] [Related]  

  • 17. [Measurement of activated clotting time during cardiopulmonary bypass in infective endocarditis patients].
    Jiang L; Yu JF
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):167-9. PubMed ID: 17344611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pitfalls of Commonly Used Anticoagulation Monitoring Techniques in Antiphospholipid Syndrome During Cardiopulmonary Bypass.
    Cameron M; Al Aamri I
    J Cardiothorac Vasc Anesth; 2021 Feb; 35(2):585-588. PubMed ID: 32595067
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiphospholipid syndrome: intraoperative and postoperative anticoagulation in cardiac surgery.
    Weiss S; Nyzio JB; Cines D; Detre J; Milas BL; Narula N; Floyd TF
    J Cardiothorac Vasc Anesth; 2008 Oct; 22(5):735-9. PubMed ID: 18922433
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiphospholipid antibodies.
    Misita CP; Moll S
    Circulation; 2005 Jul; 112(3):e39-44. PubMed ID: 16027261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.